<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml producer="poppler" version="0.48.0">
<page number="1" position="absolute" top="0" left="0" height="1262" width="892">
	<fontspec id="0" size="10" family="Times" color="#231f20"/>
	<fontspec id="1" size="16" family="Times" color="#231f20"/>
	<fontspec id="2" size="14" family="Times" color="#231f20"/>
	<fontspec id="3" size="14" family="Times" color="#231f20"/>
	<fontspec id="4" size="13" family="Times" color="#231f20"/>
	<fontspec id="5" size="22" family="Times" color="#231f20"/>
	<fontspec id="6" size="25" family="Times" color="#231f20"/>
	<fontspec id="7" size="7" family="Times" color="#231f20"/>
	<fontspec id="8" size="14" family="Times" color="#231f20"/>
<text top="108" left="106" width="210" height="12" font="0">Archives of the Balkan Medical Union</text>
<text top="122" left="106" width="226" height="12" font="0">Copyright © 2019 Balkan Medical Union</text>
<text top="108" left="635" width="151" height="12" font="0">vol. 54, no. 2, pp. 339-344</text>
<text top="122" left="728" width="59" height="12" font="0">June 2019</text>
<text top="577" left="457" width="12" height="18" font="1">R</text>
<text top="581" left="469" width="43" height="13" font="0">ÉSUMÉ</text>
<text top="612" left="457" width="329" height="19" font="2"><b>Le dysfonctionnement sexuel chez les patients at-</b></text>
<text top="631" left="457" width="112" height="19" font="2"><b>teints de psoriasis</b></text>
<text top="668" left="457" width="333" height="19" font="3">Le psoriasis est une maladie inflammatoire chronique </text>
<text top="687" left="457" width="330" height="19" font="3">qui affecte la vie des patients. La qualité de vie est géné-</text>
<text top="706" left="457" width="334" height="19" font="3">ralement réduite en raison de multiples comorbidités, </text>
<text top="724" left="457" width="334" height="19" font="3">traitements, stigmatisation et fausses perceptions de </text>
<text top="743" left="457" width="333" height="19" font="3">cette maladie. La dysfonction sexuelle chez les femmes </text>
<text top="762" left="457" width="333" height="19" font="3">et les hommes est un changement dans la qualité de </text>
<text top="781" left="457" width="333" height="19" font="3">vie de ces patients en plus de ceux énumérés ci-dessus. </text>
<text top="799" left="457" width="334" height="19" font="3">Parce que la reconnaissance du dysfonctionnement </text>
<text top="818" left="457" width="329" height="19" font="3">sexuel par le patient peut être considérée comme dif-</text>
<text top="837" left="457" width="334" height="19" font="3">ficile et honteuse, il est nécessaire que le médecin de </text>
<text top="856" left="457" width="333" height="19" font="3">famille intervienne pour améliorer la santé sexuelle de </text>
<text top="874" left="457" width="74" height="19" font="3">ces patients.</text>
<text top="916" left="457" width="77" height="16" font="4">Mots-clés: </text>
<text top="912" left="537" width="249" height="19" font="3">psoriasis, dysfonctionnement sexuel, co-</text>
<text top="931" left="457" width="69" height="19" font="3">morbidités.</text>
<text top="577" left="106" width="12" height="18" font="1">A</text>
<text top="581" left="118" width="55" height="13" font="0">BSTRACT</text>
<text top="612" left="106" width="333" height="19" font="3">Psoriasis is a chronic inflammatory disease that affects </text>
<text top="631" left="106" width="334" height="19" font="3">the patients’ quality of life. In psoriatic patients, the </text>
<text top="649" left="106" width="329" height="19" font="3">quality of life is generally low due to multiple co-mor-</text>
<text top="668" left="106" width="334" height="19" font="3">bidities, treatments, stigma and misperceptions about </text>
<text top="687" left="106" width="333" height="19" font="3">this condition. Sexual dysfunction, in both women </text>
<text top="706" left="106" width="330" height="19" font="3">and men, is a comorbidity that may impact the qual-</text>
<text top="724" left="106" width="334" height="19" font="3">ity of life of these patients, in addition to those listed </text>
<text top="743" left="106" width="334" height="19" font="3">above. Because the recognition of sexual dysfunction </text>
<text top="762" left="106" width="329" height="19" font="3">by the patient can be difficult and considered shame-</text>
<text top="781" left="106" width="333" height="19" font="3">ful, it is necessary for the family doctor to intervene to </text>
<text top="799" left="106" width="266" height="19" font="3">improve the sexual health of these patients.</text>
<text top="841" left="106" width="74" height="16" font="4">Keywords: </text>
<text top="837" left="184" width="252" height="19" font="3">psoriasis, sexual dysfunction, comorbidi-</text>
<text top="856" left="106" width="25" height="19" font="3">ties.</text>
<text top="200" left="653" width="133" height="24" font="5">MINIREVIEW</text>
<text top="311" left="106" width="636" height="27" font="6">SEXUAL DYSFUNCTION IN PATIENTS WITH PSORIASIS</text>
<text top="363" left="106" width="189" height="17" font="3">Ana Maria A. STANESCU¹</text>
<text top="362" left="295" width="3" height="10" font="7"> </text>
<text top="363" left="306" width="319" height="17" font="3">, Ioana V. GRAJDEANU ¹, Bogdan SERBAN¹</text>
<text top="362" left="624" width="3" height="10" font="7">,</text>
<text top="363" left="627" width="138" height="17" font="3">², Ovidiu G. BRATU</text>
<text top="362" left="766" width="15" height="10" font="7">1,3</text>
<text top="363" left="781" width="10" height="17" font="3">, </text>
<text top="381" left="106" width="113" height="17" font="3">Bogdan SOCEA</text>
<text top="381" left="220" width="15" height="10" font="7">1,4</text>
<text top="381" left="235" width="165" height="17" font="3">, Camelia C. DIACONU</text>
<text top="381" left="400" width="15" height="10" font="7">1,5</text>
<text top="405" left="106" width="491" height="19" font="3">¹ University of Medicine and Pharmacy “Carol Davila“, Bucharest, Romania</text>
<text top="424" left="106" width="430" height="19" font="3">² Emergency Universitary Hospital Bucharest, Bucharest, Romania</text>
<text top="443" left="106" width="5" height="11" font="7">3</text>
<text top="443" left="111" width="676" height="19" font="3"> Emergency Universitary Central Military Hospital, Academy of Romanian Scientists, Bucharest, Romania</text>
<text top="462" left="106" width="5" height="11" font="7">4</text>
<text top="461" left="111" width="438" height="19" font="3"> Emergency Clinical Hospital „Sf. Pantelimon“, Bucharest, Romania</text>
<text top="481" left="106" width="5" height="11" font="7">5</text>
<text top="480" left="111" width="414" height="19" font="3"> Clinical Emergency Hospital of Bucharest, Bucharest, Romania</text>
<text top="499" left="506" width="281" height="19" font="8"><i>Received 08 March 2019, Accepted 22 Apr 2019</i></text>
<text top="522" left="550" width="236" height="12" font="0">https://doi.org/10.31688/ABMU.2019.54.2.19</text>
<text top="1096" left="143" width="167" height="13" font="0"> Address for correspondence:  </text>
<text top="1096" left="348" width="131" height="13" font="0"> Ana Maria A. STANESCU</text>
<text top="1113" left="348" width="417" height="13" font="0">Address: Intrarea Pinului no. 34, bl. 6, ap. 10, sector 6, 060564, Bucharest, </text>
<text top="1130" left="348" width="47" height="13" font="0">Romania</text>
<text top="1148" left="348" width="187" height="13" font="0">E-mail: alexandrazotta@yahoo.com</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="1262" width="892">
	<fontspec id="9" size="11" family="Times" color="#231f20"/>
<text top="91" left="106" width="372" height="14" font="9">Sexual dysfunction in patients with psoriasis – STANESCU et al</text>
<text top="1182" left="106" width="143" height="14" font="9">340  /  vol. 54, no. 2</text>
<text top="126" left="106" width="5" height="18" font="1">I</text>
<text top="130" left="112" width="85" height="13" font="0">NTRODUCTION</text>
<text top="161" left="136" width="304" height="19" font="3">Psoriasis is a chronic, inflammatory, disfiguring </text>
<text top="179" left="106" width="333" height="19" font="3">disease, with an estimated prevalence between 1% </text>
<text top="198" left="106" width="119" height="19" font="3">and 8.5% globally</text>
<text top="199" left="224" width="12" height="11" font="7">1,2</text>
<text top="198" left="236" width="204" height="19" font="3">. Psoriasis is a chronic disease </text>
<text top="216" left="106" width="334" height="19" font="3">that affects patients’ quality of life more than other </text>
<text top="235" left="106" width="282" height="19" font="3">chronic diseases, mainly due to skin damage.</text>
<text top="253" left="136" width="306" height="19" font="3">World Health Organization (WHO) defines </text>
<text top="272" left="106" width="329" height="19" font="3">sexual health as a state of physical, emotional, men-</text>
<text top="290" left="106" width="333" height="19" font="3">tal and social well-being related to sexuality; it is not </text>
<text top="309" left="106" width="334" height="19" font="3">just the absence of illness, dysfunction or infirmity³. </text>
<text top="327" left="106" width="333" height="19" font="3">For sexual health to be achieved and maintained, the </text>
<text top="346" left="106" width="330" height="19" font="3">sexual rights of all individuals must be respected, pro-</text>
<text top="364" left="106" width="128" height="19" font="3">tected and fulfilled³.</text>
<text top="383" left="136" width="300" height="19" font="3">One-fourth of patients with psoriasis have sexu-</text>
<text top="401" left="106" width="329" height="19" font="3">ally-affected lives after the onset of psoriasis, regard-</text>
<text top="420" left="106" width="333" height="19" font="3">less of gender. Sexual dysfunction is one of the causal </text>
<text top="438" left="106" width="334" height="19" font="3">factors in reducing the quality of life in patients with </text>
<text top="457" left="106" width="330" height="19" font="3">psoriasis, along with low self-esteem, anxiety, depres-</text>
<text top="475" left="106" width="330" height="19" font="3">sion and suicidal ideation. Sexual dysfunction in pso-</text>
<text top="494" left="106" width="334" height="19" font="3">riasis is influenced by factors such as the severity of </text>
<text top="512" left="106" width="333" height="19" font="3">psoriasis, psoriasis body area, associated physical and/ </text>
<text top="531" left="106" width="149" height="19" font="3">or psychic comorbidities</text>
<text top="532" left="255" width="5" height="11" font="7">4</text>
<text top="531" left="260" width="176" height="19" font="3">. 40.8% of patients with pso-</text>
<text top="549" left="106" width="180" height="19" font="3">riasis have sexual dysfunction</text>
<text top="550" left="287" width="5" height="11" font="7">5</text>
<text top="549" left="291" width="148" height="19" font="3">. Several dermatological </text>
<text top="568" left="106" width="333" height="19" font="3">conditions, in addition to psoriasis, may affect sexual </text>
<text top="586" left="106" width="334" height="19" font="3">function, including: lichen simplex, chronic eczema, </text>
<text top="605" left="106" width="181" height="19" font="3">vitiligo and chronic urticaria</text>
<text top="606" left="288" width="5" height="11" font="7">6</text>
<text top="605" left="292" width="143" height="19" font="3">. Some studies have re-</text>
<text top="623" left="106" width="334" height="19" font="3">ported both erectile dysfunction and impotence due </text>
<text top="642" left="106" width="296" height="19" font="3">to drugs used in psoriasis, such as methotrexate</text>
<text top="643" left="401" width="5" height="11" font="7">7</text>
<text top="642" left="406" width="4" height="19" font="3">.</text>
<text top="660" left="136" width="305" height="19" font="3">In family doctor’s practice, sexual dysfunction </text>
<text top="679" left="106" width="333" height="19" font="3">in patients with psoriasis is too little approached. </text>
<text top="697" left="106" width="333" height="19" font="3">From this point of view, it is necessary to make the </text>
<text top="716" left="106" width="333" height="19" font="3">family doctor aware of the risk of sexual dysfunction </text>
<text top="734" left="106" width="334" height="19" font="3">in these patients. Patients often feel uncomfortable </text>
<text top="753" left="106" width="329" height="19" font="3">about addressing this issue, and it is primarily nec-</text>
<text top="771" left="106" width="333" height="19" font="3">essary for the family doctor’s initiative to initiate </text>
<text top="790" left="106" width="335" height="19" font="3">patient discussion on the subject. The subsequent </text>
<text top="808" left="106" width="334" height="19" font="3">approach depends on each patient and their needs, </text>
<text top="827" left="106" width="329" height="19" font="3">on the severity of psoriasis, the areas of the body af-</text>
<text top="845" left="106" width="334" height="19" font="3">fected by psoriasis, the associated comorbidities and </text>
<text top="864" left="106" width="153" height="19" font="3">the treatments followed.</text>
<text top="903" left="106" width="11" height="18" font="1">S</text>
<text top="907" left="117" width="39" height="13" font="0">EXUAL</text>
<text top="903" left="156" width="5" height="18" font="1"> </text>
<text top="907" left="162" width="84" height="13" font="0">DYSFUNCTION</text>
<text top="903" left="245" width="5" height="18" font="1"> </text>
<text top="907" left="251" width="12" height="13" font="0">IN</text>
<text top="903" left="263" width="5" height="18" font="1"> </text>
<text top="907" left="269" width="27" height="13" font="0">MEN</text>
<text top="938" left="136" width="304" height="19" font="3">Erectile dysfunction is defined as persistence of </text>
<text top="957" left="106" width="333" height="19" font="3">the inability to achieve or maintain an erection during </text>
<text top="975" left="106" width="115" height="19" font="3">sexual intercourse</text>
<text top="976" left="221" width="5" height="11" font="7">8</text>
<text top="975" left="226" width="214" height="19" font="3">. Psoriasis affects self-confidence, </text>
<text top="994" left="106" width="333" height="19" font="3">due to the unattractive and embarrassing impression, </text>
<text top="1012" left="106" width="333" height="19" font="3">especially in the case of exacerbation of psoriasis. </text>
<text top="1031" left="106" width="334" height="19" font="3">Rejection due to psoriasis is encountered by 44.7% </text>
<text top="1049" left="106" width="44" height="19" font="3">of men</text>
<text top="1050" left="150" width="5" height="11" font="7">9</text>
<text top="1049" left="154" width="4" height="19" font="3">.</text>
<text top="1068" left="136" width="300" height="19" font="3">The main cause of erectile dysfunction is con-</text>
<text top="1086" left="106" width="334" height="19" font="3">sidered to be atherosclerosis, but other factors such </text>
<text top="1105" left="106" width="333" height="19" font="3">as psychosocial factors or lifestyle contribute to this </text>
<text top="1123" left="106" width="330" height="19" font="3">dysfunction. Hormonal disorders also play an impor-</text>
<text top="1142" left="106" width="333" height="19" font="3">tant role, especially in patients with psoriasis, which </text>
<text top="126" left="457" width="333" height="19" font="3">is characterized by low levels of total testosterone and </text>
<text top="145" left="457" width="172" height="19" font="3">increased levels of estradiol</text>
<text top="146" left="629" width="9" height="11" font="7">10</text>
<text top="145" left="638" width="153" height="19" font="3">. Erectile dysfunction is </text>
<text top="164" left="457" width="333" height="19" font="3">also influenced by the presence of chronic diseases </text>
<text top="183" left="457" width="83" height="19" font="3">and by aging.</text>
<text top="201" left="487" width="300" height="19" font="3">Psoriasis is associated with numerous comorbidi-</text>
<text top="220" left="457" width="333" height="19" font="3">ties, such as dyslipidemia, obesity, metabolic syndrome, </text>
<text top="239" left="457" width="335" height="19" font="3">diabetes, hypertension, depression and a sedentary </text>
<text top="258" left="457" width="333" height="19" font="3">lifestyle. Hence, the question arises as to the extent </text>
<text top="277" left="457" width="334" height="19" font="3">to which erectile dysfunction is affected by the skin </text>
<text top="295" left="457" width="329" height="19" font="3">involvement in psoriasis and/or associated comorbidi-</text>
<text top="314" left="457" width="333" height="19" font="3">ties, which themselves can lead to erectile dysfunction. </text>
<text top="333" left="457" width="329" height="19" font="3">On the other hand, erectile dysfunction is a cardiovas-</text>
<text top="352" left="457" width="334" height="19" font="3">cular risk marker, as compared to the cardiovascular </text>
<text top="371" left="457" width="333" height="19" font="3">risk exposure of a moderately smoker¹¹. Cardiovascular </text>
<text top="389" left="457" width="329" height="19" font="3">events may occur 3-5 years after the diagnosis of erec-</text>
<text top="408" left="457" width="334" height="19" font="3">tile dysfunction, the early diagnosis being important </text>
<text top="427" left="457" width="248" height="19" font="3">for the patient’s cardiovascular approach</text>
<text top="428" left="704" width="20" height="11" font="7">12,13</text>
<text top="427" left="724" width="4" height="19" font="3">.</text>
<text top="446" left="487" width="300" height="19" font="3">As an independent risk factor, psoriasis in com-</text>
<text top="465" left="457" width="333" height="19" font="3">bination with arthritis (psoriatic arthritis) exposes the </text>
<text top="484" left="457" width="334" height="19" font="3">patient to a much greater risk of developing erectile </text>
<text top="502" left="457" width="329" height="19" font="3">dysfunction due to inflammation that sustains en-</text>
<text top="521" left="457" width="334" height="19" font="3">dothelial dysfunction, with vascular function being </text>
<text top="540" left="457" width="53" height="19" font="3">affected.</text>
<text top="559" left="487" width="304" height="19" font="3">Besides the presence of arthritis, the severity of </text>
<text top="578" left="457" width="334" height="19" font="3">psoriasis is another factor that generally determines </text>
<text top="596" left="457" width="333" height="19" font="3">the  degree  of  erectile  dysfunction.  However,  one </text>
<text top="615" left="457" width="334" height="19" font="3">study showed the presence of erectile dysfunction in </text>
<text top="634" left="457" width="334" height="19" font="3">46.6% of patients with severe psoriasis and 56% in </text>
<text top="653" left="457" width="87" height="19" font="3">mild psoriasis</text>
<text top="653" left="543" width="9" height="11" font="7">14</text>
<text top="653" left="552" width="4" height="19" font="3">.</text>
<text top="672" left="487" width="300" height="19" font="3">There is a two-way relationship between psoria-</text>
<text top="690" left="457" width="334" height="19" font="3">sis and periodontitis, where systemic inflammation </text>
<text top="709" left="457" width="329" height="19" font="3">produced by psoriasis can increase the severity of per-</text>
<text top="728" left="457" width="329" height="19" font="3">iodontitis, the outbreak of infection acting as a trig-</text>
<text top="747" left="457" width="334" height="19" font="3">gering factor in psoriasis (periodontal disease causes </text>
<text top="766" left="457" width="334" height="19" font="3">vascular endothelial infection, local growth of white </text>
<text top="785" left="457" width="334" height="19" font="3">cells, tissue growth factors and endotoxins, favoring </text>
<text top="803" left="457" width="251" height="19" font="3">atherosclerosis and erectile dysfunction)</text>
<text top="804" left="707" width="9" height="11" font="7">15</text>
<text top="803" left="717" width="4" height="19" font="3">.</text>
<text top="843" left="457" width="11" height="18" font="1">S</text>
<text top="847" left="468" width="39" height="13" font="0">EXUAL</text>
<text top="843" left="507" width="5" height="18" font="1"> </text>
<text top="847" left="512" width="84" height="13" font="0">DYSFUNCTION</text>
<text top="843" left="596" width="5" height="18" font="1"> </text>
<text top="847" left="602" width="12" height="13" font="0">IN</text>
<text top="843" left="614" width="5" height="18" font="1"> </text>
<text top="847" left="620" width="47" height="13" font="0">WOMEN</text>
<text top="878" left="487" width="304" height="19" font="3">Due  to  the  stigma  that  occurs  in  psoriasis, </text>
<text top="897" left="457" width="333" height="19" font="3">women have problems with sexual dysfunction, too. </text>
<text top="916" left="457" width="334" height="19" font="3">Still, the causal mechanism is not fully known and </text>
<text top="935" left="457" width="333" height="19" font="3">the assessment of the degree of sexual dysfunction in </text>
<text top="954" left="457" width="184" height="19" font="3">women is difficult to achieve.</text>
<text top="972" left="487" width="303" height="19" font="3">Kurizky, in a study published in 2013, found the </text>
<text top="991" left="457" width="334" height="19" font="3">presence of sexual dysfunction in 68% of the 150 </text>
<text top="1010" left="457" width="318" height="19" font="3">women with psoriasis who participated in the study</text>
<text top="1011" left="774" width="9" height="11" font="7">16</text>
<text top="1010" left="783" width="8" height="19" font="3">. </text>
<text top="1029" left="457" width="334" height="19" font="3">Meeuwis et al found the sexual dysfunction present </text>
<text top="1048" left="457" width="240" height="19" font="3">in 48.7% of 102 women with psoriasis</text>
<text top="1048" left="696" width="9" height="11" font="7">17</text>
<text top="1048" left="704" width="4" height="19" font="3">.</text>
<text top="1067" left="487" width="300" height="19" font="3">The Woman’s Sexual Index Questionnaire eval-</text>
<text top="1085" left="457" width="330" height="19" font="3">uates: pain, desire, satisfaction, lubrication, excite-</text>
<text top="1104" left="457" width="334" height="19" font="3">ment and orgasm; the most affected in patients with </text>
<text top="1123" left="457" width="334" height="19" font="3">psoriasis is sexual desire while lubrication and pain </text>
<text top="1142" left="457" width="265" height="19" font="3">are less common in patients with psoriasis</text>
<text top="1142" left="721" width="20" height="11" font="7">16,18</text>
<text top="1142" left="741" width="4" height="19" font="3">.</text>
</page>
<page number="3" position="absolute" top="0" left="0" height="1262" width="892">
	<fontspec id="10" size="11" family="Times" color="#231f20"/>
<image top="125" left="161" width="312" height="248" src="/export/freefileconvert/20491_db586630b15e139bb10e1af8fd8be59470242285a16126d6065fc9c3d74d2e87-3_1.png"/>
<image top="125" left="472" width="260" height="297" src="/export/freefileconvert/20491_db586630b15e139bb10e1af8fd8be59470242285a16126d6065fc9c3d74d2e87-3_2.png"/>
<image top="372" left="161" width="312" height="100" src="/export/freefileconvert/20491_db586630b15e139bb10e1af8fd8be59470242285a16126d6065fc9c3d74d2e87-3_3.png"/>
<image top="422" left="472" width="260" height="50" src="/export/freefileconvert/20491_db586630b15e139bb10e1af8fd8be59470242285a16126d6065fc9c3d74d2e87-3_4.png"/>
<text top="91" left="552" width="235" height="14" font="9">Archives of the Balkan Medical Union</text>
<text top="1182" left="661" width="42" height="14" font="9">June </text>
<text top="1182" left="693" width="94" height="14" font="9">2019 / 341</text>
<text top="535" left="136" width="304" height="19" font="3">The topography of cutaneous lesions (especially </text>
<text top="554" left="106" width="334" height="19" font="3">the genital area, abdomen, thighs and back) plays an </text>
<text top="574" left="106" width="333" height="19" font="3">important role in sexual dysfunction. A prevalence of </text>
<text top="593" left="106" width="317" height="19" font="3">psoriasis at the genital level of 35%-42% was shown</text>
<text top="594" left="423" width="9" height="11" font="7">19</text>
<text top="593" left="432" width="8" height="19" font="3">. </text>
<text top="613" left="106" width="334" height="19" font="3">The presence of genital lesions in psoriasis generally </text>
<text top="633" left="106" width="329" height="19" font="3">does not interfere with sexual function, women ex-</text>
<text top="652" left="106" width="333" height="19" font="3">perience a feeling of lack of attractiveness that causes </text>
<text top="672" left="106" width="333" height="19" font="3">them  to  have  sexual  dysfunction  more  frequent. </text>
<text top="692" left="106" width="333" height="19" font="3">Another factor to consider is the severity of psoriasis, </text>
<text top="711" left="106" width="329" height="19" font="3">with sexual dysfunction being more common in peo-</text>
<text top="731" left="106" width="333" height="19" font="3">ple with severe psoriasis compared to moderate and </text>
<text top="751" left="106" width="87" height="19" font="3">mild psoriasis</text>
<text top="751" left="193" width="9" height="11" font="7">20</text>
<text top="751" left="202" width="4" height="19" font="3">.</text>
<text top="770" left="136" width="300" height="19" font="3">Because psoriasis may be accompanied by pruri-</text>
<text top="790" left="106" width="334" height="19" font="3">tus, bleeding, desquamation, and joint damage, they </text>
<text top="810" left="106" width="334" height="19" font="3">may be considered as elements that are contributing </text>
<text top="829" left="106" width="329" height="19" font="3">negatively (depending on the severity of each indi-</text>
<text top="849" left="106" width="185" height="19" font="3">vidual) to sexual dysfunction.</text>
<text top="869" left="136" width="304" height="19" font="3">Depression and anxiety are already seen as an </text>
<text top="888" left="106" width="333" height="19" font="3">important part of psoriatic disease. The psychological </text>
<text top="908" left="106" width="333" height="19" font="3">connection between psoriasis and sexual dysfunction </text>
<text top="927" left="106" width="333" height="19" font="3">is represented by depression. Increases in TNF-a and </text>
<text top="947" left="106" width="333" height="19" font="3">IL-1 in psoriasis may be associated with depression, </text>
<text top="967" left="106" width="333" height="19" font="3">depression and anxiety being proved to have a higher </text>
<text top="986" left="106" width="333" height="19" font="3">frequency in patients with psoriasis compared to the </text>
<text top="1006" left="106" width="120" height="19" font="3">general population</text>
<text top="1007" left="226" width="20" height="11" font="7">21,22</text>
<text top="1006" left="247" width="193" height="19" font="3">. It can be considered a chain </text>
<text top="1026" left="106" width="335" height="19" font="3">response, psoriasis predisposing to depression and </text>
<text top="1045" left="106" width="284" height="19" font="3">depression contributes to sexual dysfunction.</text>
<text top="1086" left="106" width="11" height="18" font="1">P</text>
<text top="1090" left="118" width="81" height="13" font="0">ERSPECTIVES</text>
<text top="1086" left="199" width="5" height="18" font="1"> </text>
<text top="1090" left="205" width="25" height="13" font="0">AND</text>
<text top="1086" left="230" width="5" height="18" font="1"> </text>
<text top="1090" left="235" width="74" height="13" font="0">DISCUSSION</text>
<text top="1122" left="136" width="304" height="19" font="3">Although there are not many studies regarding </text>
<text top="1142" left="106" width="333" height="19" font="3">this issue, the treatment of psoriasis (both topical and </text>
<text top="535" left="457" width="334" height="19" font="3">systemic) can influence sexual dysfunction in both </text>
<text top="554" left="457" width="35" height="19" font="3">sexes.</text>
<text top="574" left="487" width="305" height="19" font="3">Some topical therapies may exhibit irritation </text>
<text top="593" left="457" width="334" height="19" font="3">and toxicity when used for genital psoriasis, topical </text>
<text top="613" left="457" width="334" height="19" font="3">corticosteroids (low potency), and calcitriol may give </text>
<text top="632" left="457" width="333" height="19" font="3">less atrophy or irritation in the genital area than high </text>
<text top="652" left="457" width="145" height="19" font="3">potency corticosteroids</text>
<text top="653" left="602" width="9" height="11" font="7">23</text>
<text top="652" left="611" width="4" height="19" font="3">.</text>
<text top="672" left="487" width="306" height="19" font="3">Sexual dysfunction and erectile dysfunction </text>
<text top="691" left="457" width="333" height="19" font="3">have  been  associated  with  the  administration  of </text>
<text top="711" left="457" width="230" height="19" font="3">methotrexate and etretinate/acitretin</text>
<text top="711" left="687" width="9" height="11" font="7">24</text>
<text top="711" left="696" width="94" height="19" font="3">. Methotrexate </text>
<text top="730" left="457" width="333" height="19" font="3">is  commonly  used  in  the  treatment  of  psoriasis. </text>
<text top="750" left="457" width="329" height="19" font="3">Decreased libido, infertility and impaired spermato-</text>
<text top="769" left="457" width="329" height="19" font="3">genesis have been mentioned as very rare adverse ef-</text>
<text top="789" left="457" width="329" height="19" font="3">fects, in addition cases of erectile dysfunction and gy-</text>
<text top="809" left="457" width="194" height="19" font="3">necomastia have been detected</text>
<text top="809" left="651" width="9" height="11" font="7">25</text>
<text top="809" left="660" width="130" height="19" font="3">. In association with </text>
<text top="828" left="457" width="333" height="19" font="3">depression,  treatment with isotretinoin, acitretin and </text>
<text top="848" left="457" width="329" height="19" font="3">etretinate has induced in some cases erectile dysfunc-</text>
<text top="867" left="457" width="184" height="19" font="3">tion, which can be reversible</text>
<text top="868" left="641" width="21" height="11" font="7">26,27</text>
<text top="867" left="662" width="129" height="19" font="3">. Also, especially in </text>
<text top="887" left="457" width="335" height="19" font="3">women, the possibility of vulvovaginal candidiasis </text>
<text top="906" left="457" width="333" height="19" font="3">due to medication should be considered, which may </text>
<text top="926" left="457" width="329" height="19" font="3">be an important factor in female sexual dysfunction.</text>
<text top="946" left="487" width="304" height="19" font="3">Cyclosporine appears not to be associated with </text>
<text top="965" left="457" width="333" height="19" font="3">sexual dysfunction. Biological anti-TNF, ustekinumab </text>
<text top="985" left="457" width="330" height="19" font="3">and anti-IL-17A therapies improve sexual life in pa-</text>
<text top="1004" left="457" width="329" height="19" font="3">tients with psoriasis, most likely due to good treat-</text>
<text top="1024" left="457" width="330" height="19" font="3">ment results, with the possibility of psoriasis remis-</text>
<text top="1043" left="457" width="26" height="19" font="3">sion</text>
<text top="1044" left="483" width="21" height="11" font="7">28,29</text>
<text top="1043" left="504" width="4" height="19" font="3">.</text>
<text top="1063" left="487" width="304" height="19" font="3">Because psoriasis has many comorbidities, their </text>
<text top="1083" left="457" width="335" height="19" font="3">treatment (non-steroidal anti-inflammatory drugs, </text>
<text top="1102" left="457" width="335" height="19" font="3">antidepressants, H1 antagonists, muscle relaxants, </text>
<text top="1122" left="457" width="330" height="19" font="3">proton pump inhibitors, anxiolytics and some anti-</text>
<text top="1141" left="457" width="282" height="19" font="3">hypertensives) may affect the sexual function</text>
<text top="1142" left="740" width="28" height="11" font="7">5,30,31</text>
<text top="1141" left="767" width="4" height="19" font="3">.</text>
<text top="479" left="229" width="434" height="15" font="10"><b>Figure 1. </b>Possible influences on sexual dysfunction in patients with psoriasis</text>
</page>
<page number="4" position="absolute" top="0" left="0" height="1262" width="892">
<image top="125" left="457" width="331" height="239" src="/export/freefileconvert/20491_db586630b15e139bb10e1af8fd8be59470242285a16126d6065fc9c3d74d2e87-4_1.png"/>
<image top="363" left="457" width="331" height="96" src="/export/freefileconvert/20491_db586630b15e139bb10e1af8fd8be59470242285a16126d6065fc9c3d74d2e87-4_2.png"/>
<text top="91" left="106" width="372" height="14" font="9">Sexual dysfunction in patients with psoriasis – STANESCU et al</text>
<text top="1182" left="106" width="143" height="14" font="9">342  /  vol. 54, no. 2</text>
<text top="126" left="136" width="304" height="19" font="3">Al-Mazeedi et al in 2006 reported that sexual </text>
<text top="145" left="106" width="330" height="19" font="3">dysfunction was present in 38.9% of patients with se-</text>
<text top="164" left="106" width="330" height="19" font="3">vere psoriasis included in the study and 29.7% of pa-</text>
<text top="182" left="106" width="334" height="19" font="3">tients with moderate psoriasis, while 30.8% of those </text>
<text top="201" left="106" width="281" height="19" font="3">with mild psoriasis had sexual dysfunction</text>
<text top="202" left="388" width="9" height="11" font="7">20</text>
<text top="201" left="397" width="43" height="19" font="3">. This </text>
<text top="220" left="106" width="333" height="19" font="3">study is in contradiction with many other studies that </text>
<text top="239" left="106" width="334" height="19" font="3">have shown that the higher the severity of psoriasis, </text>
<text top="257" left="106" width="247" height="19" font="3">the lower sexual dysfunction is present.</text>
<text top="276" left="136" width="305" height="19" font="3">Patients who have lesions in the genital area </text>
<text top="295" left="106" width="333" height="19" font="3">have a lower score in terms of quality of life than the </text>
<text top="314" left="106" width="334" height="19" font="3">rest of patients with psoriasis, as shown by Meeuwis </text>
<text top="332" left="106" width="26" height="19" font="3">et al</text>
<text top="333" left="132" width="9" height="11" font="7">17</text>
<text top="332" left="141" width="4" height="19" font="3">.</text>
<text top="351" left="136" width="304" height="19" font="3">Gupta et al found in the group of patients with </text>
<text top="370" left="106" width="329" height="19" font="3">psoriasis and sexual dysfunction compared with pa-</text>
<text top="389" left="106" width="334" height="19" font="3">tients with psoriasis without sexual dysfunction the </text>
<text top="407" left="106" width="334" height="19" font="3">following: decreased sexual activity after triggering </text>
<text top="426" left="106" width="329" height="19" font="3">psoriasis at 40.8%, presence of joint pain at 77%, sig-</text>
<text top="445" left="106" width="333" height="19" font="3">nificant presence of depression and higher tendency </text>
<text top="464" left="106" width="122" height="19" font="3">to consume alcohol</text>
<text top="464" left="229" width="5" height="11" font="7">5</text>
<text top="464" left="233" width="4" height="19" font="3">.</text>
<text top="482" left="136" width="304" height="19" font="3">Guenther et al followed the frequency of sexual </text>
<text top="501" left="106" width="333" height="19" font="3">dysfunction according to the sex of the patient. After </text>
<text top="520" left="106" width="333" height="19" font="3">direct correction with the PASI score, the presence of </text>
<text top="539" left="106" width="334" height="19" font="3">sexual dysfunction in the female sex was revealed by </text>
<text top="557" left="106" width="269" height="19" font="3">27.1% compared to the male with 20.8%²².</text>
<text top="576" left="136" width="300" height="19" font="3">Although several authors associate sexual dys-</text>
<text top="595" left="106" width="329" height="19" font="3">function in psoriasis with depression, sexual dysfunc-</text>
<text top="614" left="106" width="333" height="19" font="3">tion due to depression has been reported to be about </text>
<text top="632" left="106" width="334" height="19" font="3">sex drive, while sexual dysfunction due to psoriasis </text>
<text top="651" left="106" width="333" height="19" font="3">has been associated with orgasm disorder, meaning </text>
<text top="670" left="106" width="330" height="19" font="3">that sexual dysfunction in psoriasis may not be re-</text>
<text top="689" left="106" width="118" height="19" font="3">lated of depression</text>
<text top="689" left="224" width="9" height="11" font="7">18</text>
<text top="689" left="233" width="4" height="19" font="3">.</text>
<text top="707" left="136" width="304" height="19" font="3">Sexual dysfunction in patients with psoriasis is </text>
<text top="726" left="106" width="333" height="19" font="3">complex, with components such as sexual intercourse </text>
<text top="745" left="106" width="333" height="19" font="3">involving psychological factors, and components such </text>
<text top="764" left="106" width="334" height="19" font="3">as erection and orgasm related to psychological and </text>
<text top="782" left="106" width="109" height="19" font="3">physical factors³².</text>
<text top="801" left="136" width="300" height="19" font="3">The complexity of sexual dysfunction is evi-</text>
<text top="820" left="106" width="335" height="19" font="3">denced by the low quality of life in most patients </text>
<text top="839" left="106" width="333" height="19" font="3">with psoriasis. The vicious circle is highlighted by the </text>
<text top="857" left="106" width="333" height="19" font="3">limitation of physical effort, mainly due to pruritus, </text>
<text top="876" left="106" width="334" height="19" font="3">irritation and pain, resulting in sexual dysfunction. </text>
<text top="895" left="106" width="334" height="19" font="3">Another component of the vicious circle is psoriatic </text>
<text top="914" left="106" width="333" height="19" font="3">arthritis that can lead to sexual dysfunction, due both </text>
<text top="932" left="106" width="249" height="19" font="3">to psoriatic lesions and also to joint pain</text>
<text top="933" left="356" width="21" height="11" font="7">20,33</text>
<text top="932" left="377" width="63" height="19" font="3">. The fear </text>
<text top="951" left="106" width="333" height="19" font="3">of isolation and rejection, that many patients with </text>
<text top="970" left="106" width="334" height="19" font="3">psoriasis have, can also lead to sexual dysfunction, </text>
<text top="989" left="106" width="334" height="19" font="3">especially because of the patient’s desire to hide the </text>
<text top="1007" left="106" width="42" height="19" font="3">lesions</text>
<text top="1008" left="149" width="9" height="11" font="7">34</text>
<text top="1007" left="158" width="4" height="19" font="3">.</text>
<text top="1026" left="136" width="304" height="19" font="3">Russo et al showed that 26% of patients with </text>
<text top="1045" left="106" width="334" height="19" font="3">psoriasis face family tension due to the disease, but </text>
<text top="1064" left="106" width="333" height="19" font="3">also with various workplace difficulties in 40% of the </text>
<text top="1082" left="106" width="32" height="19" font="3">cases</text>
<text top="1083" left="139" width="9" height="11" font="7">35</text>
<text top="1082" left="148" width="293" height="19" font="3">. Family tension leads to sexual dysfunction </text>
<text top="1101" left="106" width="103" height="19" font="3">among partners.</text>
<text top="1120" left="136" width="300" height="19" font="3">Several studies have followed the sexual dysfunc-</text>
<text top="1139" left="106" width="333" height="19" font="3">tion in patients with psoriasis. These studies over </text>
<text top="538" left="457" width="333" height="19" font="3">time have found the prevalence of sexual dysfunction </text>
<text top="557" left="457" width="262" height="19" font="3">in psoriasis ranging from 22.6% to 71.3%</text>
<text top="558" left="719" width="16" height="11" font="7">4,36</text>
<text top="557" left="736" width="4" height="19" font="3">.</text>
<text top="576" left="487" width="300" height="19" font="3">Because family medicine pursues chronic pa-</text>
<text top="594" left="457" width="329" height="19" font="3">tients, course of treatment, and has a general over-</text>
<text top="613" left="457" width="334" height="19" font="3">view of the general state of the patient over time, it </text>
<text top="632" left="457" width="329" height="19" font="3">should primarily look at the occurrence of sexual dys-</text>
<text top="651" left="457" width="334" height="19" font="3">function in these patients. Patients may be reluctant </text>
<text top="669" left="457" width="334" height="19" font="3">to discuss sexual dysfunction, but the same problem </text>
<text top="688" left="457" width="333" height="19" font="3">can be experienced by family doctors, who often have </text>
<text top="707" left="457" width="333" height="19" font="3">difficulty in directly addressing the sexual intercourse </text>
<text top="726" left="457" width="150" height="19" font="3">during the consultation</text>
<text top="726" left="608" width="20" height="11" font="7">37,38</text>
<text top="726" left="629" width="162" height="19" font="3">. Family doctors can face </text>
<text top="744" left="457" width="333" height="19" font="3">difficulties in addressing sexual concerns due to lack </text>
<text top="763" left="457" width="335" height="19" font="3">of time, fear of offending the patient and to little </text>
<text top="782" left="457" width="209" height="19" font="3">knowledge on some sexual aspect</text>
<text top="783" left="667" width="9" height="11" font="7">39</text>
<text top="782" left="676" width="4" height="19" font="3">.</text>
<text top="801" left="487" width="304" height="19" font="3">Aschka et al found that only 12% of the patients </text>
<text top="819" left="457" width="329" height="19" font="3">studied had medical consultations for sexual prob-</text>
<text top="838" left="457" width="333" height="19" font="3">lems, most of them prefer that the doctor to be the </text>
<text top="857" left="457" width="259" height="19" font="3">initiator of the discussion about sexuality</text>
<text top="858" left="716" width="9" height="11" font="7">40</text>
<text top="857" left="726" width="4" height="19" font="3">.</text>
<text top="897" left="457" width="12" height="18" font="1">C</text>
<text top="901" left="469" width="77" height="13" font="0">ONCLUSIONS</text>
<text top="932" left="487" width="305" height="19" font="3">Psoriasis affects the quality of life of patients </text>
<text top="951" left="457" width="329" height="19" font="3">on the physical, mental and sexual level. Sexual dys-</text>
<text top="969" left="457" width="333" height="19" font="3">function among patients with psoriasis is common in </text>
<text top="988" left="457" width="333" height="19" font="3">both men and women. The causes of psoriasis-related </text>
<text top="1007" left="457" width="335" height="19" font="3">sexual dysfunction are multiple, and more studies </text>
<text top="1026" left="457" width="334" height="19" font="3">are needed to accurately determine the relationship </text>
<text top="1044" left="457" width="329" height="19" font="3">between psoriasis and sexual dysfunction. It is ob-</text>
<text top="1063" left="457" width="334" height="19" font="3">vious and necessary to address the patient in terms </text>
<text top="1082" left="457" width="333" height="19" font="3">of sexual health. The evaluation and management of </text>
<text top="1101" left="457" width="333" height="19" font="3">sexual dysfunction should start in the family doctor’s </text>
<text top="1119" left="457" width="334" height="19" font="3">office, and it is necessary to establish the limitations </text>
<text top="1138" left="457" width="236" height="19" font="3">and involvement of the family doctor.</text>
<text top="467" left="482" width="284" height="15" font="10"><b>Figure 2. </b>The vicious circle of sexual dysfunction </text>
<text top="484" left="552" width="139" height="15" font="9">in patients with psoriasis</text>
</page>
<page number="5" position="absolute" top="0" left="0" height="1262" width="892">
	<fontspec id="11" size="11" family="Times" color="#231f20"/>
<text top="91" left="552" width="235" height="14" font="9">Archives of the Balkan Medical Union</text>
<text top="1182" left="660" width="42" height="14" font="9">June </text>
<text top="1182" left="693" width="94" height="14" font="9">2019 / 343</text>
<text top="126" left="106" width="267" height="15" font="4">Compliance with Ethics Requirements:</text>
<text top="141" left="136" width="304" height="19" font="8"><i>„The authors declare no conflict of interest regarding </i></text>
<text top="159" left="106" width="65" height="19" font="8"><i>this article“</i></text>
<text top="178" left="136" width="153" height="19" font="8"><i>„No funding for this study“</i></text>
<text top="237" left="106" width="12" height="18" font="1">R</text>
<text top="241" left="118" width="71" height="13" font="0">EFERENCES</text>
<text top="272" left="106" width="329" height="15" font="9">1.  Langham S, Langham J, Goertz HP, et al. Large-scale, pro-</text>
<text top="288" left="128" width="311" height="15" font="9">spective, observational studies in patients with psoriasis and </text>
<text top="304" left="128" width="312" height="15" font="9">psoriatic arthritis: a systematic and critical view. <i>BMC Med </i></text>
<text top="320" left="128" width="148" height="15" font="11"><i>Res Methodol.</i> 2011;11:32–32.</text>
<text top="335" left="106" width="333" height="15" font="9">2.  Parisi R, Symmons DP, Griffiths CE, et al. Identification </text>
<text top="351" left="128" width="312" height="15" font="9">and management of psoriasis and associated comorbidity </text>
<text top="367" left="128" width="308" height="15" font="9">project team. Global epidemiology of psoriasis: a system-</text>
<text top="383" left="128" width="311" height="15" font="9">atic review of incidence and prevalence. <i>J Invest Dermatol.</i> </text>
<text top="399" left="128" width="109" height="15" font="9">2013;133(2):377–385.</text>
<text top="415" left="106" width="335" height="15" font="9">3.  World Health Organization – WHO. Defining sexual </text>
<text top="431" left="128" width="308" height="15" font="9">health. [Accessed March 6, 2019]. <i>Available from</i>: http://</text>
<text top="446" left="128" width="308" height="15" font="9">www.who.int/reproductivehealth/topics/sexual_health/</text>
<text top="462" left="128" width="99" height="15" font="9">sh_definitions/en/</text>
<text top="478" left="106" width="333" height="15" font="9">4.  Kurizky PS, Mota LM. Sexual dysfunction in patients with </text>
<text top="494" left="128" width="311" height="15" font="9">psoriasis and psoriatic arthritis-a systematic review. <i>Rev Bras </i></text>
<text top="510" left="128" width="158" height="15" font="11"><i>Reumatol. </i>2012;52(6):943–948.</text>
<text top="526" left="106" width="335" height="15" font="9">5.  Gupta MA, Gupta AK. Psoriasis and sex: a study of </text>
<text top="542" left="128" width="311" height="15" font="9">moderately to severely affected patients. <i>Int J Dermatol.</i> </text>
<text top="557" left="128" width="105" height="15" font="9">1997;36(4):259–262.</text>
<text top="573" left="106" width="334" height="15" font="9">6.  Sukan M, Maner F. The problems in sexual functions of </text>
<text top="589" left="128" width="311" height="15" font="9">vitiligo and chronic urticaria patients<i>. J Sex Marital Ther.</i> </text>
<text top="605" left="128" width="93" height="15" font="9">2007;33(1):55–64.</text>
<text top="621" left="106" width="333" height="15" font="9">7.  Wylie G, Evans CD, Gupta G. Reduced libido and erectile </text>
<text top="637" left="128" width="312" height="15" font="9">dysfunction: rarely reported side-effects of methotrexate. </text>
<text top="653" left="128" width="182" height="15" font="11"><i>Clin Exp Dermatol</i> 2009;34(7):e234.</text>
<text top="669" left="106" width="330" height="15" font="9">8.  Hackett G, Dean J, Kell P. British society for sexual medi-</text>
<text top="684" left="128" width="311" height="15" font="9">cine guidelines on the management of erectile dysfunction. </text>
<text top="700" left="128" width="308" height="15" font="9">[Accessed May 7, 2019]. <i>Available from</i>: www.bssm.org.uk/</text>
<text top="716" left="128" width="293" height="15" font="9">downloads/BSSM_ED_Management_Guidelines_2007.</text>
<text top="732" left="106" width="333" height="15" font="9">9.  Wojciechowska-Zdrojowy M, Reich A, Szepietowski JC, et </text>
<text top="748" left="128" width="312" height="15" font="9">al. Analysis of sexual problems in men with psoriasis. <i>J Sex </i></text>
<text top="764" left="128" width="171" height="15" font="11"><i>Marital Ther.</i> 2018 Apr 12; Epub.</text>
<text top="780" left="106" width="333" height="15" font="9">10.  Eltaweel A, Mustafa AI, El-Shimi OS, et al. Sex hormones, </text>
<text top="795" left="128" width="312" height="15" font="9">erectile dysfunction, and psoriasis; a bad friendship! <i>Int J </i></text>
<text top="811" left="128" width="169" height="15" font="11"><i>Dermatol</i>. 2018;57(12):1481-1484.</text>
<text top="827" left="106" width="333" height="15" font="9">11.  Thompson IM, Tangen CM, Goodman PJ, et al. Erectile </text>
<text top="843" left="128" width="311" height="15" font="9">dysfunction and subsequent cardiovascular disease. <i>JAMA</i>. </text>
<text top="859" left="128" width="133" height="15" font="9">2005;294(23):2996–3002.</text>
<text top="875" left="106" width="333" height="15" font="9">12.  Watts GF, Chew KK, Stuckey BG. The erectile-endothelial </text>
<text top="891" left="128" width="311" height="15" font="9">dysfunction nexus: new opportunities for cardiovascular risk </text>
<text top="906" left="128" width="308" height="15" font="9">prevention. <i>Nat Clin Pract Cardiovasc Med</i>. 2007;4(5):263–</text>
<text top="922" left="128" width="22" height="15" font="9">273.</text>
<text top="938" left="106" width="332" height="15" font="9">13.  Jackson G, Boon N, Eardley I, et al. Erectile dysfunction and </text>
<text top="954" left="128" width="311" height="15" font="9">coronary artery disease prediction: evidence-based guidance </text>
<text top="970" left="128" width="270" height="15" font="9">and consensus. <i>Int J Clin Pract</i>. 2010;64(7):848–857.</text>
<text top="986" left="106" width="333" height="15" font="9">14.  Bardazzi F, Odorici G, Ferrara F, et al. Sex and the PASI: </text>
<text top="1002" left="128" width="308" height="15" font="9">patients affected by a mild form of psoriasis are more pre-</text>
<text top="1018" left="128" width="311" height="15" font="9">disposed to have a more severe form of erectile dysfunction. </text>
<text top="1033" left="128" width="270" height="15" font="11"><i>J Eur Acad Dermatol Venereol.</i> 2016;30(8):1342–1348.</text>
<text top="1049" left="106" width="334" height="15" font="9">15. Zuo Z, Jiang J, Jiang R, et al. Effect of periodontitis on </text>
<text top="1065" left="128" width="311" height="15" font="9">erectile function and its possible mechanism. <i>J Sex Med.</i> </text>
<text top="1081" left="128" width="112" height="15" font="9">2011;8(9):2598–2605.</text>
<text top="1097" left="106" width="333" height="15" font="9">16. Kurizky PS. Avaliação da ocorrência de di sfunção sexual </text>
<text top="1113" left="128" width="308" height="15" font="9">nas pacientes com psoríase e artrite psoriásica: um es-</text>
<text top="1129" left="128" width="311" height="15" font="9">tudo tipo caso-controle de 150 mulheres brasileiras. Tese </text>
<text top="1144" left="128" width="311" height="15" font="9">(mestrado em Ciências Médicas) – Faculdade de Medicina, </text>
<text top="126" left="478" width="308" height="15" font="9">Universidade de Brasília; Brasília: 2013. http://repositorio.</text>
<text top="142" left="478" width="153" height="15" font="9">unb.br/handle/10482/15073</text>
<text top="158" left="457" width="333" height="15" font="9">17.  Meeuwis KA, de Hullu JA, van de Nieuwenhof HP, et al . </text>
<text top="174" left="478" width="311" height="15" font="9">Quality of life and sexual health in patients with genital </text>
<text top="190" left="478" width="246" height="15" font="9">psoriasis. <i>Br J Dermatol.</i> 2011;164(6):1247–1255.</text>
<text top="206" left="457" width="333" height="15" font="9">18. Türel Ermertcan A, Temeltaș G, Deveci A, et al. Sexual </text>
<text top="222" left="478" width="315" height="15" font="9">dysfunction  in  patients  with  psoriasis.  <i>J Dermatol. </i></text>
<text top="238" left="478" width="111" height="15" font="9">2006;33(11):772–778.</text>
<text top="253" left="457" width="333" height="15" font="9">19.  Meeuwis KAP, Potts Bleakman A, van de Kerkhof PCM, et </text>
<text top="269" left="478" width="312" height="15" font="9">al. Prevalence of genital psoriasis in patients with psoriasis. </text>
<text top="285" left="478" width="143" height="15" font="11"><i>J Dermatolog Treat.</i> 2018:1–7</text>
<text top="301" left="457" width="332" height="15" font="9">20.  Al-Mazeedi K, El-Shazly M, Al-Ajmi HS. Impact of psoriasis </text>
<text top="317" left="478" width="308" height="15" font="9">on quality of life in Kuwait<i>. Int J Dermatol.</i> 2006;45(4):418–</text>
<text top="333" left="478" width="22" height="15" font="9">424.</text>
<text top="349" left="457" width="333" height="15" font="9">21.  Molina-Leyva A, Almodovar-Real A, Carrascosa JC, et al. </text>
<text top="365" left="478" width="311" height="15" font="9">Distribution pattern of psoriasis, anxiety and depression as </text>
<text top="381" left="478" width="308" height="15" font="9">possible causes of sexual dysfunction in patients with mod-</text>
<text top="397" left="478" width="308" height="15" font="9">erate to severe psoriasis. <i>An Bras Dermatol</i>. 2015;90(3):338–</text>
<text top="413" left="478" width="22" height="15" font="9">345.</text>
<text top="428" left="457" width="333" height="15" font="9">22.  Guenther L, Han C, Szapary P, et al. Impact of ustekinumab </text>
<text top="444" left="478" width="308" height="15" font="9">on health-related quality of life and sexual difficulties associ-</text>
<text top="460" left="478" width="311" height="15" font="9">ated with psoriasis: results from two phase III clinical trials. </text>
<text top="476" left="478" width="255" height="15" font="11"><i>J Eur Acad Dermatol Venereol. </i>2011;25(7):851–857.</text>
<text top="492" left="457" width="332" height="15" font="9">23.  Menter A, Korman NJ, Elmets CA, et al. Guidelines of care </text>
<text top="508" left="478" width="311" height="15" font="9">for the management of psoriasis and psoriatic arthritis<i>. J Am </i></text>
<text top="524" left="478" width="180" height="15" font="11"><i>Acad Dermatol.</i> 2011;65(1):137–174.</text>
<text top="540" left="457" width="333" height="15" font="9">24.  Mercan S, Altunay IK, Demir B, et al. Sexual dysfunctions </text>
<text top="556" left="478" width="311" height="15" font="9">in patients with neurodermatitis and psoriasis<i>. J Sex Marital </i></text>
<text top="572" left="478" width="135" height="15" font="11"><i>Ther</i>. 2008;34(2):160–168.</text>
<text top="588" left="457" width="333" height="15" font="9">25.  Theodosiou  G,  Svensson  Å.  Methotrexate-associated </text>
<text top="603" left="478" width="311" height="15" font="9">sexual dysfunction: two case reports. <i>Acta Derm Venereol.</i> </text>
<text top="619" left="478" width="113" height="15" font="9">2017;97(9):1132–1133.</text>
<text top="635" left="457" width="330" height="15" font="9">26.  Rossi M, Pellegrino M. Acitretin-associated erectile dysfunc-</text>
<text top="651" left="478" width="202" height="15" font="9">tion: a case report. <i>Cases J.</i> 2009;2:210.</text>
<text top="667" left="457" width="333" height="15" font="9">27.  Tirado Sánchez A, León Dorantes G. Erectile dysfunction </text>
<text top="683" left="478" width="308" height="15" font="9">during isotretinoin therapy. <i>Actas Urol Esp.</i> 2005;29(10):974–</text>
<text top="699" left="478" width="22" height="15" font="9">976.</text>
<text top="715" left="457" width="333" height="15" font="9">28. Dong X, Zheng Y, Shi TY, et al. Effects of tumor necrosis </text>
<text top="731" left="478" width="308" height="15" font="9">factor-alpha on sexual activity of male patients with ankylos-</text>
<text top="747" left="478" width="272" height="15" font="9">ing spondylitis. <i>Clin Rheumatol.</i> 2015;34(5):915–920.</text>
<text top="763" left="457" width="329" height="15" font="9">29.  Ryan C, Menter A, Guenther L. Efficacy and safety of ixeki-</text>
<text top="779" left="478" width="311" height="15" font="9">zumab in a randomized, double-blinded, placebo-controlled </text>
<text top="794" left="478" width="311" height="15" font="9">phase 3b study of patients with moderate-to-severe genital </text>
<text top="810" left="478" width="233" height="15" font="9">psoriasis. <i>Br J Dermatol</i>. 2018;179(4):844-852.</text>
<text top="826" left="457" width="335" height="15" font="9">30. Dobrica EC, Gaman MA, Cozma MA, et al. Sinus </text>
<text top="842" left="478" width="311" height="15" font="9">bradycardia in a young female. <i>Arch Balk Med Union</i> </text>
<text top="858" left="478" width="103" height="15" font="9">2018;53(4):603-607.</text>
<text top="874" left="457" width="329" height="15" font="9">31.  Diaconescu D, Stoian AP, Socea LI, et al. Hepatorenal syn-</text>
<text top="890" left="478" width="299" height="15" font="9">drome: a review. <i>Arch Balk Med Union</i> 2018;53(2):239-245.</text>
<text top="906" left="457" width="329" height="15" font="9">32.  McMahon CG, Jannini E, Waldinger M, et al. Standard op-</text>
<text top="922" left="478" width="308" height="15" font="9">erating procedures in the disorders of orgasm and ejacula-</text>
<text top="938" left="478" width="170" height="15" font="9">tion. <i>J Sex Med.</i> 2013;10:204–229</text>
<text top="954" left="457" width="332" height="15" font="9">33.  Iftimie G, Bratu OG, Socea B, et al. Pulmonary involvement </text>
<text top="969" left="478" width="311" height="15" font="9">in rheumatoid arthritis – another face of the coin. <i>Archives </i></text>
<text top="985" left="478" width="238" height="15" font="11"><i>of the Balkan Medical Union</i> 2018; 53(1): 89-95.</text>
<text top="1001" left="457" width="333" height="15" font="9">34.  Silva KS. Psoríase e sua relação com aspectos psicológicos, </text>
<text top="1017" left="478" width="284" height="15" font="9">stress e eventos da vida. <i>Est Psicol.</i> 2007;24(2):257–266.</text>
<text top="1033" left="457" width="329" height="15" font="9">35.  Russo PA, Ilchef R, Cooper AJ. Psychiatric morbidity in pso-</text>
<text top="1049" left="478" width="292" height="15" font="9">riasis: a review. <i>Australas J Dermatol.</i> 2004;45(3):155–159</text>
<text top="1065" left="457" width="333" height="15" font="9">36. Kurizky PS, Martins GA, Carneiro JN, Gomes CM, Mota </text>
<text top="1081" left="478" width="311" height="15" font="9">LMHD. Evaluation of the occurrence of sexual dysfunction </text>
<text top="1097" left="478" width="312" height="15" font="9">and general quality of life in female patients with psoriasis. </text>
<text top="1113" left="478" width="200" height="15" font="11"><i>An Bras Dermatol. </i>2018;93(6):801–806.</text>
<text top="1129" left="457" width="333" height="15" font="9">37. Goodwach R. Let’s talk about sex. <i>Aust Fam Physician</i>. </text>
<text top="1144" left="478" width="77" height="15" font="9">2017;46:14–18.</text>
</page>
<page number="6" position="absolute" top="0" left="0" height="1262" width="892">
<text top="91" left="106" width="372" height="14" font="9">Sexual dysfunction in patients with psoriasis – STANESCU et al</text>
<text top="1182" left="106" width="143" height="14" font="9">344  /  vol. 54, no. 2</text>
<text top="126" left="106" width="335" height="15" font="9">38. Stefani C, Grajdeanu IV, Serban B, et al. Abordarea </text>
<text top="142" left="128" width="312" height="15" font="9">depresiei în practica medicului de familie. <i>Revista Medicala </i></text>
<text top="158" left="128" width="149" height="15" font="11"><i>Romana</i> 2019;LXVI(1):24-28.</text>
<text top="173" left="106" width="333" height="15" font="9">39.  Nicolosi A, Buvat J, Glasser DB, et al. Sexual behaviour, </text>
<text top="189" left="128" width="312" height="15" font="9">sexual dysfunctions and related help seeking patterns in </text>
<text top="126" left="478" width="308" height="15" font="9">middle-aged and elderly Europeans: the global study of sex-</text>
<text top="142" left="478" width="308" height="15" font="9">ual attitudes and behaviours. <i>World J Urol.</i> 2006;24(4):423–</text>
<text top="158" left="478" width="22" height="15" font="9">428.</text>
<text top="173" left="457" width="333" height="15" font="9">40.  Aschka C, Himmel W, Ittner E, et al. Sexual problems of </text>
<text top="189" left="478" width="308" height="15" font="9">male patients in family practice. <i>J Fam Pract.</i> 2001;50(9):773–</text>
<text top="205" left="478" width="22" height="15" font="9">778.</text>
</page>
</pdf2xml>
